Abstract: A system for assisting endoscope tracking used to track a travel path of an endoscope probe within an organ includes three position sensors and three distance sensors which are surrounding an endoscope probe, and a computing device. The said three position sensors respectively sense a first coordinate, a second coordinate and a third coordinate relative to a navigation origin. The said three distance sensors respectively sense a first distance, a second distance and a third distance apart from an inner wall of the organ. The computing device obtains a position coordinate of the endoscope probe relative to the navigation origin according to the first coordinate, the second coordinate and the third coordinate. The computing device further determines whether to send a warning message according to the first distance, the second distance and the third distance.

Abstract: Disclosed herein are inhibitors of the GGDPS enzyme, and methods for their use in treating or preventing diseases, such as multiple myeloma. The inhibitors described herein can include compounds of Formula (I) and pharmaceutically acceptable salts thereof: wherein the substituents are described.

Abstract: The present disclosure relates to a method and apparatus for control action based on software-defined networking associated with quantum key distribution network (QKDN) management in a quantum key distribution network. A method for performing a control action associated with QKDN management in a QKDN according to an embodiment of the present disclosure may include: receiving, by a first control entity, control action information from a QKDN manager; determining, by the first control entity, a target of the control action based on the control action information; classifying, by the first control entity, the control action sequentially as one of a routing or rerouting-related control action, a provisioning-related control action, a protection or recovery-related control action, and a charge-related control action based on the target of the control action; and transmitting, by the first control entity, information for performing the control action for a target associated with the classified control action.

Abstract: The present invention relates to a novel anticancer peptide. The anticancer peptide inhibits cancer cell proliferation and metastasis, induces cell death, and relieves drug resistance, and thus may be utilized for an anticancer use and an anticancer adjuvant.

Abstract: There is provided a method for estimating a pose of an object using 3 dimensional modeling transform by transforming a 3D partial point cloud including partial points for the object to a 3D full point cloud for the object.

Abstract: The present disclosure relates to compositions and methods for predicting cancer survival or toxicity in a subject receiving a chimeric antigen receptor (CAR) T cell therapy. The present disclosure further discloses compositions, e.g., pharmaceutical compositions, and methods for treating said subject.

Abstract: A method for power allocation in a dAP may comprise: when a change cycle of a transmit power determination vector arrives, generating an uplink message including long-term CSI, the uplink message being normalized such that the long-term local CSI becomes a value within a preconfigured limit range; transmitting the uplink message to a central processing unit through a fronthaul; receiving a downlink message vector for power allocation from the central processing unit through the fronthaul; generating decentralized determination information using the downlink message vector; and extracting a transmit power determination vector based on the decentralized determination information.

Abstract: The present disclosure is that plating steel with spangles can be subjected to constant humidity heat treatment. Due to this, the degree of blackening is different depending on the spangle pattern, and then a black plated steel sheet having a marble texture and a beautiful pattern can be obtained when the blackening is completed.

Abstract: A system, method, apparatus and diagnostic test for Plasmodium vivax, to determine a likelihood of a specific timing of infection by P. vivax in a subject, and hence identify individuals with a high probability of being infected with otherwise undetectable liver-stage hypnozoites. The system, method, apparatus and diagnostic test relate to the identification of hypnozoites (“dormant” liver-stages), or at least of the likelihood of the subject being so infected. Optionally and preferably, the specific timing relates to recent infections, for example within the last 9 months.

Abstract: A vertical type apparatus for firing a cathode material of a secondary battery is provided. The vertical type apparatus for firing the cathode material according to the present disclosure includes a plurality of saggers, each having an open upper portion, provided with a through-slit for gas flow in a lower surface thereof, and loaded with the cathode material therein, and a plurality of unit firing furnaces, each having an open upper portion, each plurally stacked in the vertical direction, each receiving the respective sagger.

Abstract: Provided is an underlayer which may improve the resolution and sensitivity of a resist film, suppress the collapse of a resist pattern and have improved etching resistance. The underlayer includes a crosslinked material of tin-oxo nanoclusters represented by Formula 1. [(R—Sn)12O14(OH)6]2+[Rx?]2??[Formula 1] In Formula 1, R is an alkyl group of 1 to 20 carbon atoms, and Rx? is a counter anion and an alkylbenzene sulfonate anion.

Abstract: A system and method for personalized dosing of a pharmacologic agent include: executing, using a processing device, a plurality of dosing regimen program modules to determine a respective plurality of dose sets in response to receiving, from an input device, a target response value for a patient; and executing, using the processing device, a dosing selection algorithm module, following executing the plurality of dosing regimen program modules and in response to receiving from the input device a response profile and a monitoring frequency of the patient, to determine a recommended dose set computed as a combination of the plurality of dose sets weighted by degrees of matching computed using fuzzy sets and the response profile.

Abstract: The present invention relates to a strain that produces neoagarooligosaccharides from agarose, which is a representative polysaccharide constituting red algae, using Saccharomyces boulardii, which is a probiotic yeast, a production method thereof, and a use thereof. The present invention aims to achieve synbiotics through the production of prebiotic substances using probiotic strains and can be used as an intestinal microbial factory.

Abstract: Disclosed are methods, compositions, proteins, nucleic acids, cells, vectors, compounds, reagents, and systems for the preparation of kavalactones, flavokavains, and kavalactone and flavokavain biosynthetic intermediates using enzymes expressed in heterologous host cells, such as microorganisms or plants, or using in vitro enzymatic reactions. This invention also provides for the expression of the enzymes by recombinant cell lines and vectors. Furthermore, the enzymes can be components of constructs such as fusion proteins. The kavalactones produced can be utilized to treat anxiety disorder, insomnia, and other psychological and neurological disorders. The flavokavains produced can be utilized to treat various cancers including colon, bladder, and breast cancers.

Abstract: A system may include a solar cell and a modulator connected to an output of the solar cell. The system may receive a signal. When the signal being in a first state corresponding to modulation, the modulator may modulate voltage output of the solar cell and cause the solar cell to perform optical transmission. When the signal is in a second state corresponding to energy harvesting, the modulator to cease modulation of the output of the solar cell.

Abstract: The present exemplary embodiments relate to a positive electrode active material and a lithium secondary battery including the same. According to an exemplary embodiment, a positive electrode active material for a lithium secondary battery including a metal oxide particle including nickel, cobalt, manganese and aluminum, and three types of doping elements doped on the metal oxide particle is provided.

Abstract: A method for preparing an array substrate and an array substrate. The method for preparing an array substrate includes: depositing a first metal layer, an insulating layer, an active layer and a doping layer on the substrate; forming a photoresist on doping layer by using a first photomask process, and etching the photoresist to form a gate and a channel; depositing a second metal layer on the substrate; using the second photomask process to form the source-drain metal layer; depositing a passivation layer on the substrate; using the third photomask process to form a pixel electrode layer.

Abstract: Method for operating an assistance system based on an attribute space comprises: obtaining task information defining at least one target state to be achieved; obtaining initial state information defining an initial state of an autonomous device or a user, and of at least one object involved in achieving the target state; defining a planning problem based on the task information, the initial state information and attribute information related to the object; selecting an action or a sequence of actions to solve the planning problem; and outputting a control signal to a human-machine interface HMI or the autonomous device for achieving the target state; determining whether the action or sequence of actions achieves the target state, and, if not, decomposing the planning problem based on the attribute information to generate a decomposed planning problem; solving the decomposed planning problem; and outputting the control signal to the HMI or the autonomous device.

Abstract: The present application relates to vanadium compounds. More specifically, the present application relates to pharmaceutical compositions comprising vanadium salts, use thereof and methods using the same. The present application also includes compositions comprising vanadium compounds and a therapeutic or prophylactic virus providing for increased virus infection, spread, titer, activity, cytotoxicity and/or immunotherapeutic activity.

Abstract: Provided herein are methods of potentiating an effect of an anti-cancer drug in a subject diagnosed with cancer, the method including administering to the subject a combination therapy including: an effective amount of 7-ethynyl-5-(2-fluorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one (BZD-1); and an anti-cancer drug.